SIGY
Price:
$0.039
Market Cap:
$62.61K
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inf...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
SIGY
According to Sigyn Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.02. This represents a change of 116.71% compared to the average of 0.01 of the last 4 quarters.
The mean historical Current Ratio of Sigyn Therapeutics, Inc. over the last ten years is 0.33. The current 0.02 Current Ratio has changed 543.26% with respect to the historical average. Over the past ten years (40 quarters), SIGY's Current Ratio was at its highest in in the June 2021 quarter at 2.22. The Current Ratio was at its lowest in in the June 2025 quarter at 0.00.
Average
0.33
Median
0.19
Minimum
0.00
Maximum
1.13
Discovering the peaks and valleys of Sigyn Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 494.08%
Maximum Annual Current Ratio = 1.13
Minimum Annual Increase = -93.59%
Minimum Annual Current Ratio = 0.00
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.00 | -85.93% |
| 2023 | 0.03 | -4.64% |
| 2022 | 0.03 | -93.59% |
| 2021 | 0.54 | -52.50% |
| 2020 | 1.13 | 494.08% |
| 2019 | 0.19 | 18.43% |
| 2018 | 0.16 | -12.28% |
| 2017 | 0.18 | -37.32% |
| 2016 | 0.29 | -62.49% |
| 2015 | 0.78 | -25.70% |
The current Current Ratio of Sigyn Therapeutics, Inc. (SIGY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.02
5-year avg
0.35
10-year avg
0.33
Sigyn Therapeutics, Inc.’s Current Ratio is less than Acrux Limited (1.35), greater than ProtoKinetix, Incorporated (0.01), greater than AXIM Biotechnologies, Inc. (0.00), less than Zelira Therapeutics Limited (0.11), less than RepliCel Life Sciences Inc. (0.09), less than HAVN Life Sciences Inc. (4.51), less than Therma Bright Inc. (0.10), less than Pharmadrug Inc. (0.20), less than Core One Labs Inc. (0.81), less than IR-Med Inc. (0.12),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.35 | $6.78M | |
| 0.01 | $2.04M | |
| 0.00 | $1.70M | |
| 0.11 | $4.16M | |
| 0.09 | $7.00K | |
| 4.51 | $2.56K | |
| 0.10 | $1.97M | |
| 0.20 | $584.46K | |
| 0.81 | $471.00 | |
| 0.12 | $540.67K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigyn Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sigyn Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sigyn Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Sigyn Therapeutics, Inc. (SIGY)?
What is the highest Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?
What is the 3-year average Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?
What is the 5-year average Current Ratio for Sigyn Therapeutics, Inc. (SIGY)?
How does the current Current Ratio for Sigyn Therapeutics, Inc. (SIGY) compare to its historical average?